
ESTA Stock Forecast & Price Target
ESTA Analyst Ratings
Bulls say
Establishment Labs Holdings Inc. is poised for substantial growth, with management projecting revenue increases of over 20% annually from 2026 to 2028, stemming from market expansion, particularly with products like Mia and Preservé. Additionally, the company anticipates becoming cash flow positive by 2026, supported by improving margins and stronger-than-expected sales in the US and international markets. The overall outlook benefits from projected strong revenue growth, which is expected to enhance profitability and operational cash flow in the near term.
Bears say
Establishment Labs Holdings Inc. faces a challenging financial outlook, primarily due to expected revenue growth declining to less than 20%, fueled by disappointing sales of its Motiva implants in the U.S. market, alongside slow progress toward achieving profitability. Additional risks include the potential for an economic slowdown adversely affecting international sales, higher-than-expected complication rates, and the threat of a dilutive equity offering. Concerns raised about cosmetic outcomes of their products further complicate expectations for sales performance and market perception.
This aggregate rating is based on analysts' research of Establishment Labs Holdings Inc and is not a guaranteed prediction by Public.com or investment advice.
ESTA Analyst Forecast & Price Prediction
Start investing in ESTA
Order type
Buy in
Order amount
Est. shares
0 shares